Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 158

1.
2.

Mortality after deferral of treatment or no treatment for choroidal melanoma.

Straatsma BR, Diener-West M, Caldwell R, Engstrom RE; Collaborative Ocular Melanoma Study Group*.

Indian J Ophthalmol. 2018 Oct;66(10):1395-1400. doi: 10.4103/ijo.IJO_1499_18.

3.

Is Collaborative Ocular Melanoma Study (COMS) still relevant?

Honavar SG.

Indian J Ophthalmol. 2018 Oct;66(10):1385-1387. doi: 10.4103/ijo.IJO_1588_18. No abstract available.

4.

Outcomes of choroidal melanomas treated with eye physics plaques: A 25-year review.

Le BHA, Kim JW, Deng H, Rayess N, Jennelle RL, Zhou SY, Astrahan MA, Berry JL.

Brachytherapy. 2018 Nov - Dec;17(6):981-989. doi: 10.1016/j.brachy.2018.07.002. Epub 2018 Aug 3.

PMID:
30082188
5.

Dosimetric comparison between realistic ocular model and other models for COMS plaque brachytherapy with 103Pd, 131Cs, and 125I radioisotopes.

Ebrahimi-Khankook A, Vejdani-Noghreiyan A.

Radiat Environ Biophys. 2018 Jun 7. doi: 10.1007/s00411-018-0748-3. [Epub ahead of print]

PMID:
29882078
6.

Brachytherapy for patients with uveal melanoma: historical perspectives and future treatment directions.

Brewington BY, Shao YF, Davidorf FH, Cebulla CM.

Clin Ophthalmol. 2018 May 17;12:925-934. doi: 10.2147/OPTH.S129645. eCollection 2018. Review.

7.

RELATIONSHIP OF CLINICAL FEATURES AND BASELINE TUMOR SIZE WITH GENE EXPRESSION PROFILE STATUS IN UVEAL MELANOMA: A Multi-institutional Study.

Berry D, Seider M, Stinnett S, Mruthyunjaya P, Schefler AC; Ocular Oncology Study Consortium.

Retina. 2018 Mar 23. doi: 10.1097/IAE.0000000000002113. [Epub ahead of print]

PMID:
29578940
8.

Is There an Increased Prevalence of Asteroid Hyalosis in Eyes with Uveal Melanoma? A Histopathologic Study.

Burris CKH, Azari AA, Kanavi MR, Dubielzig RR, Lee V, Gottlieb JL, Potter HD, Kim K, Raven ML, Rodriguez ME, Reddy DN, Albert DM.

Ocul Oncol Pathol. 2017 Nov;3(4):259-261. doi: 10.1159/000461586. Epub 2017 Mar 24.

9.

Acute Angle Closure Precipitated by Hemorrhage and Necrosis of a Large Uveal Melanoma in the Setting of Systemic Immunomodulatory Therapy.

Pham CM, Kalyam K, Smith BT, Floyd J, Holds JB.

Ocul Oncol Pathol. 2017 Nov;3(4):254-258. doi: 10.1159/000460255. Epub 2017 Mar 24.

10.

Patterns of care and survival outcomes after treatment for uveal melanoma in the post-coms era (2004-2013): a surveillance, epidemiology, and end results analysis.

Rao YJ, Sein J, Badiyan S, Schwarz JK, DeWees T, Grigsby P, Rao PK.

J Contemp Brachytherapy. 2017 Oct;9(5):453-465. doi: 10.5114/jcb.2017.70986. Epub 2017 Oct 20.

11.

Growth of Uveal Melanoma following Intravitreal Bevacizumab.

Francis JH, Kim J, Lin A, Folberg R, Iyer S, Abramson DH.

Ocul Oncol Pathol. 2017 Jul;3(2):117-121. doi: 10.1159/000450859. Epub 2016 Nov 12.

12.

Failure modes and effects analysis for ocular brachytherapy.

Lee YC, Kim Y, Huynh JW, Hamilton RJ.

Brachytherapy. 2017 Nov - Dec;16(6):1265-1279. doi: 10.1016/j.brachy.2017.07.005. Epub 2017 Aug 18.

PMID:
28827007
13.

MRI-based treatment planning and dose delivery verification for intraocular melanoma brachytherapy.

Zoberi JE, Garcia-Ramirez J, Hedrick S, Rodriguez V, Bertelsman CG, Mackey S, Hu Y, Gach HM, Rao PK, Grigsby PW.

Brachytherapy. 2018 Jan - Feb;17(1):31-39. doi: 10.1016/j.brachy.2017.07.011. Epub 2017 Aug 14.

PMID:
28818442
14.

Stereotactic Radiosurgery and Fractionated Stereotactic Radiation Therapy for the Treatment of Uveal Melanoma.

Yazici G, Kiratli H, Ozyigit G, Sari SY, Cengiz M, Tarlan B, Mocan BO, Zorlu F.

Int J Radiat Oncol Biol Phys. 2017 May 1;98(1):152-158. doi: 10.1016/j.ijrobp.2017.02.017. Epub 2017 Feb 17.

PMID:
28586956
15.

Evaluation of dose enhancement in presence of gold nanoparticles in eye brachytherapy by 103Pd source.

Rezaei H, Zabihzadeh M, Ghorbani M, Goli Ahmadabad F, Mostaghimi H.

Australas Phys Eng Sci Med. 2017 Sep;40(3):545-553. doi: 10.1007/s13246-017-0555-1. Epub 2017 May 16.

PMID:
28509080
16.

Dosimetric and radiobiologic comparison of 103Pd COMS plaque brachytherapy and Gamma Knife radiosurgery for choroidal melanoma.

Gorovets D, Gagne NL, Melhus CS.

Brachytherapy. 2017 Mar - Apr;16(2):433-443. doi: 10.1016/j.brachy.2016.12.003. Epub 2017 Feb 1.

PMID:
28161431
17.

Delivered dose uncertainty analysis at the tumor apex for ocular brachytherapy.

Morrison H, Menon G, Larocque MP, Jans HS, Weis E, Sloboda RS.

Med Phys. 2016 Aug;43(8):4891. doi: 10.1118/1.4959540.

PMID:
27487906
18.

Investigating the dosimetric impact of seed location uncertainties in Collaborative Ocular Melanoma Study-based eye plaques.

Johnson JE, Deufel CL, Furutani KM.

Brachytherapy. 2016 Sep-Oct;15(5):661-8. doi: 10.1016/j.brachy.2016.06.002. Epub 2016 Jul 27.

PMID:
27475484
19.

Validation of a Prognostic Staging for Metastatic Uveal Melanoma: A Collaborative Study of the European Ophthalmic Oncology Group.

Kivelä TT, Piperno-Neumann S, Desjardins L, Schmittel A, Bechrakis N, Midena E, Leyvraz S, Zografos L, Grange JD, Ract-Madoux G, Marshall E, Damato B, Eskelin S.

Am J Ophthalmol. 2016 Aug;168:217-226. doi: 10.1016/j.ajo.2016.06.002. Epub 2016 Jun 11.

PMID:
27296487
20.

Outcomes of Proton Beam Radiotherapy for Large Non-Peripapillary Choroidal and Ciliary Body Melanoma at TRIUMF and the BC Cancer Agency.

Weber B, Paton K, Ma R, Pickles T.

Ocul Oncol Pathol. 2015 Sep;2(1):29-35. doi: 10.1159/000433546. Epub 2015 Jul 9.

Supplemental Content

Loading ...
Support Center